Can bright light and better sleep beat baby blues? new trial tests Drug-Free fix for perinatal depression
NCT ID NCT04364646
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a non-drug treatment called Personalized Integrated Chronotherapy (PIC) for depression during pregnancy and after childbirth. 120 pregnant women with major depression were randomly assigned to receive either usual care (medication or therapy) or PIC plus usual care. PIC combines morning bright light therapy with personalized sleep scheduling to reset the body's internal clock. The goal was to see if this approach could reduce depressive symptoms more than standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Personalized Integrated Chronotherapy (bright light therapy, sleep schedule adjustments)
- What this could lead to
- If it works, this could offer a safe, non-drug option to treat depression during and after pregnancy, improving outcomes for mothers and babies.
- What could go wrong
- This is a relatively small, early-stage trial (120 participants) and the therapy requires strict adherence to sleep schedules, which may be hard for new mothers. Results may not apply to all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
120 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- pregnant women, ages 18-45 years with a HAMD score \>=14 and a current DSM-5 diagnosis of major depressive disorder as determined with the Current Major Depression Module of the Structured Clinical Interview for DSM disorders (SCID-I/P) Exclusion Criteria: * active psychosis or suicidality contraindicating outpatient treatment as determined by the clinical judgement of the research team and as measured with the B/C module of the SCID-I/P and the Columbia-Suicide Severity Rating Scale * bipolar disorder (because sleep restriction can increase risk of conversion to mania) * seizure disorder (because sleep restriction can increase seizure risk) * self report of frequent migraines/headaches precipitated by bright light or sleep deprivation * preexisting eye/skin disorders contraindicating light therapy * use of photosensitizing medications * primary Axis I diagnosis other than MDD (e.g., anorexia nervosa, ADHD) * high risk pregnancy (e.g., conditions requiring mandatory bed rest or complex medical regimens that will interfere with study participation or conditions where poor infant outcomes are anticipated) * starting antidepressants in the 4 weeks prior to enrollment * current employment as night shift worker * Alcohol Use Disorders Identification Test (AUDIT) score \> 8 and/or Drug Abuse Screening Test (DAST) \> 1 indicating current alcohol or drug use disorders * women whose infants will not be living in the home or who will have a nighttime caregiver * Pittsburgh Sleep Quality Inventory (PSQI)190 \< 5 (i.e., those who report no sleep complaints during 3rd trimester of pregnancy and for whom an intervention targeting sleep might not be indicated). * women who do not speak and read English because PIC research instruments are only available in English at this time. If this RCT shows effectiveness, future work will examine effectiveness in women who speak and read languages other than English. * Women who experience fetal loss or stillbirth, as well as mothers whose infants are born before 36 weeks' gestation or have NICU stays \> 5 days, will be discontinued from the study but will continue to receive UC.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Circadian dysregulation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Feinstein Institute For Medical Research
Glen Oaks, New York, 11004, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a phone app that blocks distracting apps ease depression?
- Can teachers and a phone app ease teen depression?
- Can imagining exercise boost brain power after spinal cord injury?
- Can an antipsychotic restore feelings in people with depression?
- Can a group program teach teens to cope before therapy starts?